U.S. DNA-Based Diagnostic Test and Equipment Market Analysis & Directions

Published by: Fuji-Keizai USA, Inc.

Published: Sep. 2, 2009 - 184 Pages

Table of Contents

Introduction

Section A: Market Condition

1. Market Overview

1.1 Market History

Table 1-1 Important Industry Developments

1.2 Market Structure and Character

1.2.1 U.S. Regulatory Structure

1.2.2 Regulatory Update

1.3 Major Players and Character

Table 1-2 Market Participants and Their Multiple Business Models

1.4 Major Players’ Products (Product Name, Targeted Diagnostic, Price, Product Feature)

2. Market Trends, 2008-2010

2.1 Market Size and Forecast: Test Products & Equipment Markets

Table 2-1 Revenue by 15 Surveyed Companies, 2008-2010

Table 2-2 Maker (15) Share, 2008-2010

Table 2-3 Estimates of Current U.S. Market Size

2.2 Equipment & Test Product Market Trends

Table 2-4 Equipment Market Forecast, by Product Type, 2008-2010

Table 2-5 Test Product Market Size, by Test Product Segment

Table 2-6 Diagnostic Testing Product Segments

Table 2-7 Market Size Human Gene Tests, by Type of Test

3. Market Share by Product Segment of Surveyed Companies

3.1Market Share Overview 2008 vs. 2010

Table 3-1 Market Share Overview 2008 vs. 2010

3.2 Maker Shares, by Type of Test Product

3.2.1Blood Screens

Table 3-2 Maker Share

3.2.2 Infectious Diseases (Viral)

Table 3-3 Maker Share

3.2.3 Infectious Diseases (Bacterial)

Table 3-4 Maker Share

3.2.4 Human Gene Tests

Table 3-5 Maker Share

3.3 Maker Share, by Equipment

3.3.1 RT-PCR

Table 3-6 Maker Share

3.3.2 DNA Amplification and Detection

Table 3-7 Maker Share

3.3.3 Microarrays

Table 3-8 Maker Share

4. Distribution Structure

4.1 Basic Distribution Pattern

4.1.1 The Customer Continuum

4.1.2 Direct Sales to Clinical Labs - Genetic Tests as “Medical Devices”

4.1.3 Direct Sales to Physicians - Genetic Tests as “Laboratory

Service”

4.2 Sales (%) by Channel

4.3 Sales Agent Intervention and Influence

4.3.1 Physician Customers

4.3.2 Laboratory Customers

4.3.3 Clinical Labs as Distribution Partners

4.4 Distribution Character in B-to-C Business

5. New Product Development Trends

5.1 Development Trends by Product Segment

5.2 Hot New Products

6. Technology Character in DNA Diagnostic Product Development

6.1 Trends of Development/Supported Technology

6.1.1 Multiplex Testing and Genomic Hybridization

6.1.2 Multiplexed (Multi-Analyte) Platforms

6.1.3 More Choices in Gene Amplification

6.2 Development Speed and Improvement Points in Sequencing Technology

Table 6-1 Comparison of Faster (Ultrahigh-Throughput) DNA Sequencers: Commercially Available Systems

Table 6-2 New Sequencing Platforms Under Development

7. Future of Market

7.1 Market Potentiality and Roadmap

Table 7-1 Market Positioning 2010 to 2012: Major Categories of Test Products

Table 7-2 Market Positioning 2010 to 2012: DNA-based Diagnostic Tests & Key Equipment

7.2. Roadmap: Development and Drivers, 2009, 2010/11, Beyond 2012

8. Issues and Strategy for the DNA-Based Diagnostic and Test Business

8.1 Management of Individual Information (Privacy)

8.2 Organization of Ethics Committee, etc.

8.3 Current Status of DNA Counseling

8.4 Policy and Proposal by Insurance Industry

Section B: Company Case Studies (15 Companies)

Common research Item

1) Company In-Brief

-Revenue

-Location

-Established Year

-Special Note

2) Revenue by Business Segment (DNA-based Diagnostics and Tests, Drugs, Medical Equipment, etc.)

3) Product Revenue Forecasts, 2007-2009

-Equipment Revenue

-Product Revenue, by Segment

4) Most Important Product for Sales and Marketing Spending - and Key Reason for Spending on Product

5) Distribution Policy

- Basic Distribution Flow

- Status of Usage of Sales Agents, Wholesalers, etc.

6) R&D Activity

- Expenditure

- Most Important R&D Area for Capital Spending - and Key Reason for Spending

7) Technology Trends

- Technology Used in DNA-based Diagnostic and Test

- Patents Status

8) New Product Development Activity

- Product Character

- Product Development Areas where Company Invests More Money and People Resources

9) Profitability

- Revenue Contribution of DNA-based Diagnostic and Test Business

- Profitability (%) of the Above-mentioned Business

10) Business Policies

- Management of Privacy

- Company Policy on Ethics

- Status of Usage of DNA Counseling

11) Market Trends (Roadmap): Future DNA Diagnostic and Test Market Outlook

- Product Segment where Company Can Expect Brighter Future

- Market Expansion and Obstruction Factors

- Business Potentiality of B-to-C Segment

1. Abbott Molecular Diagnostics

2. Becton Dickinson (BD) Diagnostics

3. BioMérieux USA/BioTheranostics

4. Celera Corp.

5. Decode Genetics

6. Qiagen North America/Digene

7. Genomic Health

8. Gen-Probe

9. Interleukin Genetics

10. Life Technologies (formerly Applied Biosystems & Invitrogen)

11. Myriad Genetics

12. Novartis V&D

13. Roche (Molecular Diagnostics & Applied Science divisions)

14. Siemens Healthcare Diagnostics (formerly Bayer Diagnostics)

15. Hologic Molecular (formerly Third Wave Technologies)

Section C: Additional Companies in DNA-based Diagnostics, by Market Segment

Common Research Item

-Location/Contact Information

-URL

-Private or Public

-Revenue

-Current Product or

-Developing Product & Application

-Technology, R&D and Commercialization

-Strategic Alliance and Partner

1. Consumer Genomics

1.1 ~ 1.5 Total 5 Companies

2. DNA-Based Test Makers

2.1 ~ 2.8 Total 8 Companies

3. Instrumentation and Tools

3.1 ~3.14 Total 14 Companies

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.